opioids including fentanyl

User profile image Steven -

The Overdose Crisis: Spotlight on Opioids, Sedatives & Stimulants Events

Click here to register for this free webinar!

The ongoing overdose crisis in Canada has claimed the lives of over 50,000 people since 2016. Parents and professionals working with youth need to know how to protect not only themselves, but also young people who are using or considering using opioids, stimulants or sedatives for any purpose.

Join us as we explore:

0 Replies
User profile image Andrew -

Understanding Opioids in Later Life Workshop Events

Please join us on Thursday, October 24, 2024 from 1pm–2pm ET for the Understanding Opioids in Later Life Workshop. This free workshop is for older adults (65+) and their caregivers, where we will discuss:

 

1 Replies
User profile image Rupi -

Opioid-related drug toxicity deaths in Ontario shelters Forum topic

Check out this webinar that was presented in partnership with the Ontario Drug Policy Research Network (ODPRN).

Webinar recording

0 Replies
User profile image nicole -

Fentanyl Drug Test Strips Education Video Forum topic

I wanted to share this information video on the use of fentanyl strips. I find the information very helpful especially when educating clients. Thought someone else find it useful! Link is below

https://vimeo.com/923320008

0 Replies
User profile image Vincent -

Opioid Use in Primary Care Conference 2024 Events

Save the date – May 24, 2024

Opioid Use in Primary Care - Virtual Annual Conference

Designed for anyone involved in the care and support of people who use opioids, this one-day event will provide the opportunity to learn about and discuss topics related to opioid use practices, policies, treatments and harm reduction.

0 Replies
User profile image Sri -

Call for Research Participants: Family members/close supports of people who use opioids Forum topic

Are you a family member or close support of someone who used opioids during the COVID-19 pandemic? Are you interested in participating in research? You may be eligible to share your thoughts about how pandemic public health measures impacted people who use opioids!

For more information and contact details, please see the attached flyer.

0 Replies
User profile image Vincent -

Research snapshot: Genetic variant linked to poor effectiveness of methadone treatment Forum topic

Methadone and buprenorphine/naloxone are effective opioid agonist therapies (OAT) for opioid use disorder. But some people don’t achieve the outcomes they hope for. Genetic factors are known to influence a person’s risk of developing opioid use disorder, but there is little research on whether they might influence the likelihood that OAT will be effective.

Researchers investigated whether certain gene variants are associated with treatment outcomes in people receiving methadone or buprenorphine/naloxone for prescription-type opioid use disorder.

0 Replies
User profile image Leah -

"New" high-potency synthetic nitazene opioids circulating in Toronto's unregulated opioid supply Forum topic

This week (March 18), Toronto’s Drug Checking Service released two alerts regarding high-potency synthetic nitazene opioids circulating in the city's unregulated opioid supply.

The following information is summarized from their website:

Alert 1: Two new nitazene opioids identified and circulating

0 Replies
User profile image Vincent -

Webinar recording: Addressing Opioid Stigma in Pharmacies – Strategies for Pharmacy Professionals Forum topic

About the webinar

On February 16, the Centre for Addiction and Mental Health (CAMH) held a webinar event to promote the release of the 'Addressing Opioid Stigma in Pharmacies – Strategies for Pharmacy Professionals’ toolkit that provides valuable insights and resources for frontline pharmacy professionals to support people taking opioids to mitigate the negative impacts of stigma.

0 Replies
User profile image Vincent -

Webinar: Addressing Opioid Stigma in Pharmacies – Strategies for Pharmacy Professionals Events

About the webinar

Le français suit l’anglais

The Centre for Addiction and Mental Health (CAMH) is holding a webinar event to promote the release of a toolkit that provides valuable insights and resources for frontline pharmacy professionals to support people taking opioids to mitigate the negative impacts of stigma.

0 Replies
User profile image Marina -

Introduction to Opioids, Addiction & Opioid Use Disorder (Virtual) Events

This workshop covers what opioids are, their side-effects and the risks associated with misusing opioids, toxicity of the unregulated drug supply, signs of an opioid overdose, naloxone, and opioids in relation to Bipolar Disorder and Psychosis.
0 Replies
User profile image Vincent -

Save lives with this free online course Forum topic

It is estimated that six million Canadians experience addiction in their lifetime and an average of 20 die from opioid toxicity every day. CAMH has launched free online education to teach you how to use a naloxone kit to help save lives.

The new Opioid Overdose Response Training is an engaging gamified experience for you to practice responding to an opioid overdose in four steps:

0 Replies
User profile image Rossana -

Webinar recording: Caring for persons on methadone in primary care: Toward safer, more inclusive care Forum topic

Methadone is a first-line treatment for opioid use disorder and its use is associated with reduced morbidity, mortality, blood-born viral infections and social harms. Despite these benefits, methadone remains a poorly understood and stigmatized medication. Comprehensive primary care that includes integrated opioid agonist therapy results in improved preventative health screening and higher client satisfaction.

0 Replies
User profile image Andrew -

Understanding the use of opioids and other medications in later life workshop Events

Please join us on Thursday Nov 16 2023 from 1pm - 2pm for the Understanding the use of opioids and other medications in later life workshop. This free workshop is for older adults (65+) and their caregivers where we will discuss:

0 Replies